| Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association |
1488 |
| Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association |
1138 |
| 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
308 |
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
286 |
| 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons |
281 |
| Fourth Universal Definition of Myocardial Infarction (2018) |
228 |
| Status of Hypertension in China Results From the China Hypertension Survey, 2012-2015 |
193 |
| Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) |
138 |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
133 |
| Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials |
130 |
| 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
107 |
| Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus |
103 |
| Insights From the International Registry of Acute Aortic Dissection A 20-Year Experience of Collaborative Clinical Research |
100 |
| Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial |
99 |
| 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
96 |
| Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline |
92 |
| Spontaneous Coronary Artery Dissection: Current State of the Science A Scientific Statement From the American Heart Association |
88 |
| Global Burden of Atherosclerotic Cardiovascular Disease in People Living With HIV: Systematic Review and Meta-Analysis |
88 |
| A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction |
85 |
| Evaluation and Management of Right-Sided Heart Failure A Scientific Statement From the American Heart Association |
79 |
| Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies A Scientific Statement From the American Heart Association |
79 |
| Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association |
78 |
| Socioeconomic Status and Cardiovascular Outcomes Challenges and Interventions |
78 |
| Cardiovascular and Metabolic Heterogeneity of Obesity Clinical Challenges and Implications for Management |
77 |
| Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program |
75 |
| Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis |
74 |
| 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
74 |
| Cardiovascular Disease and Breast Cancer: Where These Entities Intersect A Scientific Statement From the American Heart Association |
73 |
| Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study) |
73 |
| Fully Automated Echocardiogram Interpretation in Clinical Practice: Feasibility and Diagnostic Accuracy |
70 |
| Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association |
68 |
| Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure |
66 |
| Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population |
65 |
| Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease |
64 |
| Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease The EMPA-HEART CardioLink-6 Randomized Clinical Trial |
63 |
| 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
62 |
| Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States |
62 |
| Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction Subanalysis From the DECLARE-TIMI 58 Trial |
61 |
| Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe) |
61 |
| Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups Results From the Randomized CREDENCE Trial |
61 |
| Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association |
59 |
| Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study |
59 |
| Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association |
57 |
| Newer-Generation Ultrathin Strut Drug-Eluting Stents Versus Older Second-Generation Thicker Strut Drug-Eluting Stents for Coronary Artery Disease Meta-Analysis of Randomized Trials |
57 |
| Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage |
56 |
| 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
55 |
| Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention A Consensus Document From the Academic Research Consortium for High Bleeding Risk |
55 |
| Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring A Randomized Clinical Trial |
54 |
| Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction The DEFINE-HF Trial |
54 |
| Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association |
54 |
| Loss of Super-Enhancer-Regulated circRNA Nfix Induces Cardiac Regeneration After Myocardial Infarction in Adult Mice |
53 |
| Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine |
52 |
| Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks Findings From the Swedish National Diabetes Registry |
51 |
| Twenty Year Trends and Sex Differences in Young Adults Hospitalized With Acute Myocardial Infarction The ARIC Community Surveillance Study |
51 |
| Standardized End Point Definitions for Coronary Intervention Trials The Academic Research Consortium-2 Consensus Document |
51 |
| Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association |
51 |
| Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update |
51 |
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
50 |
| Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves |
49 |
| 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines |
49 |
| Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation |
49 |
| Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome |
48 |
| Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction |
48 |
| FTO-Dependent N-6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair |
47 |
| Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association |
47 |
| Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis |
47 |
| Perioperative Myocardial Injury After Noncardiac Surgery Incidence, Mortality, and Characterization |
47 |
| Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes |
47 |
| Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study |
46 |
| Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function: Data From the CANVAS Program |
46 |
| Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion The DECISION-CTO Trial |
45 |
| Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy |
45 |
| Beclin-1-Dependent Autophagy Protects the Heart During Sepsis |
45 |
| Five-Year Clinical and Echocardiographic Outcomes From the NOTION Randomized Clinical Trial in Patients at Lower Surgical Risk |
45 |
| Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention A Global Expert Consensus Document |
45 |
| 2019 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Advanced Airways, Vasopressors, and Extracorporeal Cardiopulmonary Resuscitation During Cardiac Arrest An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care |
45 |
| Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER |
44 |
| Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury |
44 |
| Resuscitation Education Science: Educational Strategies to Improve Outcomes From Cardiac Arrest: A Scientific Statement From the American Heart Association |
43 |
| Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA- REG OUTCOME Trial |
43 |
| Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity A Scientific Statement From the American Heart Association |
43 |
| Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging |
42 |
| Myocarditis in the Setting of Cancer Therapeutics Proposed Case Definitions for Emerging Clinical Syndromes in Cardio-Oncology |
42 |
| Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association |
42 |
| Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury |
42 |
| Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction |
42 |
| H19 Induces Abdominal Aortic Aneurysm Development and Progression |
42 |
| Whole-Genome Sequencing to Characterize Monogenic and Polygenic Contributions in Patients Hospitalized With Early-Onset Myocardial Infarction |
41 |
| Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation |
41 |
| Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care A First Analysis From the EMPRISE Study |
41 |
| Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia |
41 |
| Cardiovascular Disease-Related Morbidity and Mortality in Women With a History of Pregnancy Complications Systematic Review and Meta-Analysis |
41 |
| Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA |
41 |
| Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients |
41 |
| Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association |
40 |
| Three-Year Outcomes With the Absorb Bioresorbable Scaffold: Individual-Patient-Data Meta-Analysis From the ABSORB Randomized Trials |
40 |
| Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis |
40 |
| Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation PRIME Study |
40 |
| Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality: An Individual-Level Pooled Analysis of 30 Cohort Studies |
39 |
| Regenerative Potential of Neonatal Porcine Hearts |
39 |
| 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials |
39 |
| Myocardial Scar and Mortality in Severe Aortic Stenosis: Data From the BSCMR Valve Consortium |
39 |
| Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement From the American Heart Association |
39 |
| Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update |
38 |
| Improving the Diagnostic Performance of F-18-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Prosthetic Heart Valve Endocarditis |
38 |
| Heart Failure Stimulates Tumor Growth by Circulating Factors |
38 |
| The N-6-Methyladenosine mRNA Methylase METTL3 Controls Cardiac Homeostasis and Hypertrophy |
37 |
| Associations of Variability in Blood Pressure, Glucose and Cholesterol Concentrations, and Body Mass Index With Mortality and Cardiovascular Outcomes in the General Population |
37 |
| Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy |
37 |
| Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation |
37 |
| Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial |
37 |
| Effects of Bariatric Surgery in Obese Patients With Hypertension The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension) |
37 |
| 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society |
37 |
| 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care |
36 |
| Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry |
36 |
| Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) |
36 |
| Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation |
36 |
| Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association |
35 |
| Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns Mechanistic Evidence of Left Intrahisian Block Circumvented by His Bundle Pacing |
35 |
| Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris |
35 |
| 2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces |
35 |
| Twenty-Four-Hour Blood Pressure-Lowering Effect of a Sodium-Glucose Cotransporter 2 Inhibitor in Patients With Diabetes and Uncontrolled Nocturnal Hypertension Results From the Randomized, Placebo-Controlled SACRA Study |
35 |
| Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling |
34 |
| Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment-Elevation Myocardial Infarction: A Pilot Study Using the Impella CP |
34 |
| NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?) |
34 |
| Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association |
34 |
| Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia |
33 |
| Meta-Analysis of Randomized Controlled Trials of Red Meat Consumption in Comparison With Various Comparison Diets on Cardiovascular Risk Factors |
33 |
| Genetic Variants Associated With Cancer Therapy-Induced Cardiomyopathy |
33 |
| High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study |
33 |
| Early Regenerative Capacity in the Porcine Heart |
33 |
| Cardiorenal Syndrome Revisited |
33 |
| Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy |
33 |
| Ultrasound for Lower Extremity Deep Venous Thrombosis Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference |
32 |
| Long-Term Consumption of Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Mortality in US Adults |
32 |
| Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association |
32 |
| Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies |
32 |
| Leptin-Aldosterone-Neprilysin Axis Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity |
32 |
| Cardiovascular Outcomes and Risks After Initiation of a Sodium Glucose Cotransporter 2 Inhibitor Results From the EASEL Population-Based Cohort Study (Evidence for Cardiovascular Outcomes With Sodium Glucose Cotransporter 2 Inhibitors in the Real World) |
32 |
| Association of Statin Dose With Amputation and Survival in Patients With Peripheral Artery Disease |
32 |
| Stroke Outcomes in the COMPASS Trial |
32 |
| Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy |
32 |
| International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) |
32 |
| Call to Action: Urgent Challenges in Cardiovascular Disease: A Presidential Advisory From the American Heart Association |
31 |
| Metabolic Predictors of Incident Coronary Heart Disease in Women |
31 |
| Cardiovascular Risk Reduction in High-Risk Pediatric Patients A Scientific Statement From the American Heart Association |
31 |
| Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score |
31 |
| Inflammatory and Cholesterol Risk in the FOURIER Trial |
31 |
| Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association |
31 |
| Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists |
31 |
| Hyperglycemia-Driven Inhibition of AMP-Activated Protein Kinase alpha 2 Induces Diabetic Cardiomyopathy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes In Vivo |
30 |
| High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD) A Randomized Superiority Trial |
30 |
| Use of Intracardiac Echocardiography in Interventional Cardiology: Working With the Anatomy Rather Than Fighting It |
30 |
| Open-Label Randomized Trial Comparing Oral Anticoagulation With and Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation and Stable Coronary Artery Disease Beyond 1 Year After Coronary Stent Implantation: OAC-ALONE Study |
29 |
| Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization |
29 |
| The Evolving Role of the Cardiac Catheterization Laboratory in the Management of Patients With Out-of-Hospital Cardiac Arrest A Scientific Statement From the American Heart Association |
29 |
| Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins Prespecified Secondary End Points in ORION 1 |
29 |
| Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension |
29 |
| Cardiac Troponin T and Troponin I in the General Population Comparing and Contrasting Their Genetic Determinants and Associations With Outcomes |
29 |
| Regulatory CD4(+) T Cells Recognize Major Histocompatibility Complex Class II Molecule-Restricted Peptide Epitopes of Apolipoprotein B |
29 |
| Exercise Therapy and Cardiovascular Toxicity in Cancer |
29 |
| Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus Randomized Controlled Trial |
29 |
| Genetic Lineage Tracing of Nonmyocyte Population by Dual Recombinases |
28 |
| Single-Cell Analysis of the Normal Mouse Aorta Reveals Functionally Distinct Endothelial Cell Populations |
28 |
| Preeclampsia and Cardiovascular Disease in a Large UK Pregnancy Cohort of Linked Electronic Health Records A CALIBER Study |
28 |
| High-Target Versus Low-Target Blood Pressure Management During Cardiopulmonary Bypass to Prevent Cerebral Injury in Cardiac Surgery Patients A Randomized Controlled Trial |
28 |
| Modernized Classification of Cardiac Antiarrhythmic Drugs |
28 |
| Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase Randomized, Sham-Controlled Trial |
28 |
| Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis Analysis From a Stratified Multicenter Randomized Trial |
28 |
| Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis |
28 |
| Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the HeartMate 3 Versus the HeartMate II Cardiac Pump |
28 |
| 2017 American Heart Association Focused Update on Adult Basic Life Support and Cardiopulmonary Resuscitation Quality An Update to the American Heart Association Guidelines for Cardio-pulmonary Resuscitation and Emergency Cardiovascular Care |
28 |
| Transplant-Free Survival and Interventions at 6 Years in the SVR Trial |
27 |
| Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes The ADvISED Prospective Multicenter Study |
27 |
| Long Noncoding RNA CPR (Cardiomyocyte Proliferation Regulator) Regulates Cardiomyocyte Proliferation and Cardiac Repair |
27 |
| Reversing the Cardiac Effects of Sedentary Aging in Middle Age-A Randomized Controlled Trial Implications For Heart Failure Prevention |
27 |
| Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis |
27 |
| Sex Differences in the Prevalence of, and Trends in, Cardiovascular Risk Factors, Treatment, and Control in the United States, 2001 to 2016 |
27 |
| miR-22 Is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation |
27 |
| Accuracy of Fractional Flow Reserve Derived From Coronary Angiography |
27 |
| Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome VERDICT Randomized Controlled Trial |
26 |
| Clinically Significant Bleeding With Ticagrelor Versus Clopidogrel in Korean Patients With Acute Coronary Syndromes Intended for Invasive Management A Randomized Clinical Trial |
26 |
| Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation Comparison With Doppler Echocardiography-Derived Integrative Approach |
26 |
| Sedentary Behaviors in Today's Youth: Approaches to the Prevention and Management of Childhood Obesity: A Scientific Statement From the American Heart Association |
26 |
| Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction |
26 |
| Trends in Hospitalizations and Survival of Acute Decompensated Heart Failure in Four US Communities (2005-2014): ARIC Study Community Surveillance |
26 |
| Searching for Atrial Fibrillation Poststroke A White Paper of the AF-SCREEN International Collaboration |
26 |
| Pediatric Post-Cardiac Arrest Care: A Scientific Statement From the American Heart Association |
26 |
| Exercise Intolerance in Heart Failure With Preserved Ejection Fraction Diagnosing and Ranking Its Causes Using Personalized O-2 Pathway Analysis |
26 |
| Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease Results From the Registry of Pregnancy and Cardiac Disease |
26 |
| Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy |
25 |
| Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy Results From a Nationwide Danish Cohort Study |
25 |
| Mental Stress-Induced-Myocardial Ischemia in Young Patients With Recent Myocardial Infarction Sex Differences and Mechanisms |
25 |
| Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells |
25 |
| Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial |
25 |
| Spatiotemporal Multi-Omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease |
25 |
| Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease: A Randomized Double-Blind Trial |
25 |
| Association Between Urinary Sodium and Potassium Excretion and Blood Pressure Among Adults in the United States National Health and Nutrition Examination Survey, 2014 |
25 |
| Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer |
25 |
| Association Between Early Hyperoxia Exposure After Resuscitation From Cardiac Arrest and Neurological Disability Prospective Multicenter Protocol-Directed Cohort Study |
24 |
